America's Only Medical Glove Plant Warns It Could Shut Down This Week Without Federal Contract Renewal

America's Only Medical Glove Plant Warns It Could Shut Down This Week Without Federal Contract Renewal

A Virginia manufacturer says the only domestic source of medical-grade nitrile butadiene rubber in the United States could shut down within days unless the federal government renews its support.

Scott Maier, CEO of Blue Star NBR, told Breitbart News Saturday host Matthew Boyle that his company's federal contract runs out at the end of this week. "The industry is on life support," Maier said. "Unless something happens, we're going to have to sell off this equipment."

Nitrile butadiene rubber is the synthetic material used to make the disposable gloves relied on across pharmaceutical manufacturing, food processing, defense production, and two industries getting heavy attention in Washington right now: rare earth refining and semiconductor fabrication. Workers in those plants use the gloves constantly to handle sensitive materials without contamination.

The China Numbers

Data from the U.S. International Trade Commission shows how fast this dependency built up. In 2019, during President Trump's first term, China supplied about 14.2% of U.S. medical glove imports. Other Asian countries, mostly Malaysia, Thailand, and Vietnam, supplied 85.7%. Domestic production was at zero.

By Biden's first year in office, China's share had nearly doubled to 26.8%. By 2023, it hit 44.15%, while the other Asian suppliers dropped to 53.6%.

Here's the catch Maier flagged to Boyle: even the gloves coming from Malaysia, Thailand, and Vietnam aren't really independent of China. "They all have to buy their NBR from China," Maier said. "So China kind of de facto controls 90 percent of our glove supply." That means the import percentages understate the real exposure. Even a glove stamped "Made in Vietnam" likely started as Chinese raw rubber.

Domestic production, meanwhile, only became a factor in 2023, reaching 2.22% — still a rounding error, but a nonzero one for the first time, tied to the program that built Blue Star's Wytheville, Virginia plant.

What Happened to the Money

The federal government put $123 million into Blue Star NBR's Wytheville facility, a project expected to employ roughly 2,500 people, according to reporting by Kristina Wong for Breitbart News in 2023. The plan relied on a loan package from the U.S. International Development Finance Corporation, an agency Trump authorized in 2020 specifically to backstop domestic production of pandemic-critical supplies.

That loan package didn't materialize the way the company expected. Virginia Business reported that continued funding stalled amid what Breitbart's sourcing describes as inaction from the Biden administration. The plant sits roughly 80% complete and is not yet operational.

The facility exists, taxpayers already put real money into it, and it's sitting unfinished. Whether that's due to bureaucratic slow-walking, changed federal priorities, or normal delays in a complex industrial buildout isn't fully established in available reporting. What is established is the outcome: no operational domestic NBR plant, and an industry player now saying the clock has run out.

The Fair Counterargument

A reasonable skeptic could ask whether one company's contract deadline constitutes a genuine "national security emergency," as Maier and Breitbart's framing describe it, or whether this is a single firm using urgent language to pressure the Trump administration into renewing a subsidy. Government-backed manufacturing projects routinely face funding gaps, and not every funding gap is a supply-chain crisis. Critics of industrial subsidies in general argue the market, not federal loan packages, should determine which domestic manufacturers survive.

That's a fair concern in the abstract. But it doesn't answer the specific data point at the center of this story: the USITC figures showing China's import share of U.S. medical gloves more than tripled between 2019 and 2023, while domestic capacity remained essentially nonexistent until the Blue Star project came online. Whether or not one company's contract deserves renewal, the underlying dependency trend is documented by trade data, not by Blue Star's own claims.

What's Actually at Stake

Gloves aren't glamorous, but the industries that need them are exactly the ones both parties in Washington claim to want reshored: semiconductors and rare earths. Both require huge volumes of disposable nitrile gloves for contamination control. If Blue Star shutters, the only alternative supply chain runs directly through Chinese raw material, no matter which country's name is on the box.

The Trump administration has not publicly responded to Maier's specific plea as of this writing, and no announcement on the DFC loan package or a contract extension has been made. Blue Star's stated deadline is the end of this week. What happens next, whether Washington renews support, lets the plant go idle, or finds another path, will answer whether the reshoring push has actual follow-through or just first-term-era funding announcements.